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Antidepressant Induced Mania : Is it a risk 
factor for Antidepressant abuse? 
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ABSTRACT 
Induction of mania is a common occurrence with antidepressant use. A case of 
antidepressant induced hypomania leading to antidepressant abuse is presented. 
The clinical implications of antidepressant abuse in bipolar disorder are discussed. 
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INTRODUCTION 
Induction of mania with antidepressant 
drug treatment is a common and complex 
problem. The occurrence of this 
phenomenon has been reported not only in 
patients with bipolar or unipolar disorder 
but also in obsessive-compulsive disorder 
(OCD) (Perugi et al; 1997, Swartz et al; 
1999). 
In patients of OCD with comorbid 
bipolar disorder, the prescription of 
antiobsessional drugs alone can lead to 
m<xxl destabilization and it's consequent 
complications such as non-compliance on 
mood stabilizers and even antidepressant 
abuse. We are reporting here a case of OCD 
with bipolar disorder with coexistent 
antidepressant abuse. 
CASE REPORT 
A 28 year old engineer with no past 
history or family history of psychiatric 
illness presented with a 12 year old illness, 
which began with obsessive fears of causing 
physical harm to his father. These thoughts 
caused much distress to the patient. For 
these symptoms 'he patient sought a 
psychiatnc consultation after about 1 -month 
of illness. He was provisionally diagnosed 
as a case of OCD and was started on T. 
clomipramine (150 mg/day). Within 2 weeks 
of starting clomipramine the patient 
underwent a hypomanic switch characterized 
by increased confidence, increased self-
esteem, elated mood, decreased need for 
sleep and increased energy with a significant 
decrease in his obsessive symptoms. When 
the clomipramine was tapered, the patient 
started complaining of low mood, lassitude, 
increased fatigue and worsening of his 
obsessions. He also reported missing the 
"high" induced by clomipramine. 
The obsessive symptoms changed in 
nature over the last 10 years. Currently they 
are elaborate checking and counting rituals. 
For these obsessive symptoms the patient 
had received several trials of and obsessional 
drugs including trials with fluoxetine (20-40 
mg/day), sertraline (50-150 mg/day), 
fluvoxamine (100-200 mg/day) either 
individually or in combination for several 
weeks. In addition he had also received 
trials of amineptine (100-200 mg/day) and 
venlafaxine (37.5-150 mg/day). 
During these trials, the patient had 
experienced hypomanic symptoms with 
amineptine, fluvoxamine and venlafaxine. 
These hypomanic symptoms would start 
within 3-4 days of treatment initiation and 
could last for about 1-2 weeks (maximum 
1 month). In this period the patient 
describes himself as at his creative best widi 
marked increase in his work productivity, 
increased libido and a top of die world feel 
("I am so confident that I feel I can walk 
into a cabinet meeting") with significant 
reduction in his obsessive symptoms. Even 
though the treating psychiatrist stopped the 
antidepressant drug on all occasions, the 
patient continued to surreptitiously use the 
same to experience a high. The misuse of 
die antidepressant was almost always done 
at crucial times of his life when he felt that 
the extra energy and confidence were more 
than useful. He experimented with a variety 
of antidepressants and reported mat for 
him, amineptine would reliably ("9 times 
out of 10") induce a high. 
When amineptine was withdrawn from 
die Indian market he started misusing 
fluvoxamine and venlafaxine. The latter two 
drugs would not however reliably induce a 
high. 
Six years ago die patient was started on 
Lithium (900 mg/day; serum levels 0.78 
meq/lit) with a provisional diagnosis of 
bipolar disorder NOS (DSM-IV; 1994). The 
patient is however non-compliant on lithium. 
Currently sodium valproate (1000 mg/day; 
serum levels 70 mg/ml) has been co-
prescribed with lithium on which again 
compliance is doubtful. 
DISCUSSION 
There is a relatively sparse body of 
literature regarding antidepressant abuse 
(Haddad ; 1999) Much of this literature is 
regarding amineptine abuse (Biondi et al; 
1990). The susceptibility to develop a 
hypomanic switch with antidepressants may 
be either due to the pharmacological property 
of the drug, individual susceptibility or 
both. Amineptine is a selective dopamine 
reuptake inhibitor (Barattini; 1997) The 
amphetamine like effect of this drug may 
be responsible for its abuse liability. 
Antidepressant induced mania tends to be 
milder and more time limited than in 
patients with spontaneous mania (Stoll et al; 
1994). Antidepressant induced hypomania 
may be dependant on the dose of the 
antidepressant drug (Ramasubbu R; 2001) 
and a premorbid hyperthymic temperament 
(Henry et al; 2001). Bipolar patients with 
the "S" variant of the 5HTTLPR 
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polymorphism of the serotonin transporter 
protein gene may be at a higher risk of 
antidepressant-induced mania (Mundo et al; 
2001). Such patients may also be non-
compliant on mood stabilizers. Clearly 
there is a subgroup of patients with an 
underlying bipolar diathesis who may misuse 
antidepressants. Till such patients are 
characterized both clinically and biologically, 
it is imperative to enquire for spontaneous 
or drug induced hypomania before starting 
a patient on antidepressant drugs. 
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